TSE: 3046 - JINS HOLDINGS Inc.

Yield per half year: +52.49%
Dividend yield: +1.54%
Sector: Healthcare

JINS HOLDINGS Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
26.67 110.66 -75.9% 77.05 -65.38%
P/S 1.5 75.01 -98%
P/BV 4.87 70.3 -93.08%
P/FCF 7.77 79.52 -90.23%
Ev/Ebitda 11.53 18.65 -38.18%
Ev/S 1.43 72.39 -98.03%
Ev/FCF 13 24.55 -47.06%
E/P 0.066 -0.1123 -158.78%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
12.36 -77.27 -116% 12.04 +2.67%
ROE 19.72 -9.19 -314.52%
ROA 9.45 -9.6 -198.39%
ROIC 0 9.09 -100%
ROS 5.63 -143.83 -103.91%
ROCE 25.84 6.01 329.71%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.21 -1.04 -215.77% 2.15 -43.9%
Nеt Debt/Ebitda -0.614 12.09 -105.08%
Debt/Ratio 0.2289 0.1394 64.16%
Debt/Equity 1.11 18.09 -93.85%
Debt/Net Income 2.65 -1.95 -235.95%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.85/10
1.54 2.66 -42.16% 1.19 +29.5%
Number of years of dividend growth 0 1.27 -100%
DSI 0.7143 0.7328 -2.52%
Average dividend growth -745.69 -49.62 1402.93%
Average percentage for 5 years 1.19 1.91 -37.83%
Average percentage for payments 45.54 33.37 36.47%
Difference from average difference in sector -1.12

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
37.74 53.88 -29.96%
Growth impulse Ebitda in 5 years 9.62 12.48 -22.92%
Growth impulse Net Income in 5 years 176.33 -8.53 -2167.17%
Growth impulse FCF in 5 years 76.36 -13.75 -655.35%
Growth impulse EPS in 5 years 183.71 -67.8 -370.96%
IP Score
5.94/10

Similar companies

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription